(Medical Xpress)—The party drug mephedrone can cause lasting damage to the brain, according to new research led by the University of Sydney.
Sep 19, 2012
2
0
There has been significant debate in policy circles about whether governments have over-reacted to ecstasy by issuing warnings against its use and making it illegal. In the UK, David Nutt said ecstasy was less dangerous than ...
Jul 25, 2012
2
0
(Medical Xpress) -- Researchers from UCL and Imperial College London are carrying out a neuroscience study to examine for the first time how the resting brain responds to MDMA, the pure form of the Class A drug ecstasy. The ...
Jul 24, 2012
1
0
(Medical Xpress) -- The illicit drug ‘ecstasy' is strongly associated with rave culture, but can a drug that makes people want to dance be used to develop medicines that curb involuntary movements in Parkinson's ...
Jun 14, 2012
0
1
Australian illicit drug users are turning to the internet for drug education, but not to buy drugs.
Jun 5, 2012
0
0
Secondary school-kids who use speed and ecstasy seem to be prone to subsequent depression, indicates research of almost 4000 teens published online in the Journal of Epidemiology and Community Health.
Apr 18, 2012
0
0
A study led by Case Western Reserve University School of Medicine, in collaboration with the University of East London UK, and Swansea University UK, is the first to show the effects of the drug ecstasy on fetal and infant ...
Feb 28, 2012
0
0
Since mephedrone was made illegal in the UK in 2010, the street price of the drug has risen while the quality has degraded, which in turn may have reduced use of the drug. New research published online today reveals that ...
Jan 18, 2012
0
0
Recreational use of Ecstasy – the illegal "rave" drug that produces feelings of euphoria and emotional warmth – is associated with chronic changes in the human brain, Vanderbilt University investigators have discovered.
Dec 5, 2011
0
0
The rapid emergence of synthetic new drugs, often sold online as "legal highs," represents a significant challenge for policy makers in the coming decade, a European Union drugs agency said Tuesday.
Nov 15, 2011
0
0
